ibd and glp 1 ๐จ GLP-1 RA use in is rising fast In this 14-month repeated survey of patients with IBD: ๐ GLP-1 RA use rose 5-fold โ๏ธ Median BMI fell from 35.3 โ 31.2 GLP-1 with Crohn's Disease: Safety,
Description
A secondary mechanistic analysis of the SUMMIT trial found associations between tirzepatide treatment and reductions in circulatory volume and markers of cardiac injury [85]
& Salakhutdinov, R
In the US, snack titans are already feeling the drag
We strongly advise seeking immediate medical attention if any of these symptoms occur
Researchers study how signaling peptides influence tissue response, recovery timelines, and cellular communication after stress or damage
New data for alcohol and nicotine use disorders are positive, still emerging, and there is also hope about GLP treatment for cannabis use disorder (CUD), which has accelerated quickly
